BRIANNA FURST: Open Payments
NPI 1134840812 · NORTH KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 31 payments from 20 companies in 2025. Trend: 2023 $625 · 2024 $668 · 2025 $535
Food & beverage: $535
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $83 |
| Lilly USA, LLC | 3 | $52 |
| Grifols USA, LLC | 2 | $45 |
| Amgen Inc. | 3 | $42 |
| Novo Nordisk Inc | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| SANOFI-AVENTIS U.S. LLC | 1 | $19 |
| Insulet Corporation | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
Products named: GEMTESA, JARDIANCE, Prolastin-C Liquid, OTEZLA, VOQUEZNA, TZIELD, MOUNJARO, Omnipod.
Industry payments across MO — which companies pay providers there.
